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Abstract
Trichotillomania and traction alopecia are chronic habitual disorders characterized by
repetitive pulling of  hair  that  results  in alopecia.  They are commonly observed in
children and adolescents but may present in adults due to occupational or traditional
behavioral patterns. Trichotillomania (hair‐pulling disorder) has been described more
than  a  century  ago,  but  we  still  have  very  limited  data  about  its  etiology  and
treatment. It is classified under the obsessive‐compulsive and related disorders along
with  hoarding  disorder,  skin‐picking  disorder  (excoriation)  and  body  dysmorphic
disorder  in  the  Diagnostic  and  Statistical  Manual  of  Mental  Disorders,  Fifth  Edition
(DSM‐5; American Psychiatric Association, May 2013). Traction alopecia is defined as
loss of hair caused by repetitive or continuous and prolonged tension applied to the
hair, usually on the scalp periphery and associated with mechanical traction of hair
due to occupational behavioral patterns such as ballerinas or traditional behavioral
patterns  of  hairstyles  that  cause  tension.  We  aim  to  overview  the  clinical  and
diagnostic features of trichotillomania and traction alopecia and review the therapeu‐
tic options of these disorders in this chapter.




Trichotillomania is the disorder of repetitively pulling out one's hair from different areas of the
body that results in noticeable hair loss [1]. The name trichotillomania was given to this behavior
by a French dermatologist, Francois Henri Hallopeau, in 1889; however, the disorder also appears
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in the literature in the works of Hippocrates. It is even found in plays by William Shakespeare
such as Romeo and Juliet and The Life and Death of King John. The name is derived from the
combination of Greek thrix for hair; tillein, plucking; and mania, madness.
Trichotillomania is classified under the obsessive‐compulsive and related disorders along with
hoarding disorder, skin‐picking disorder (excoriation) and body dysmorphic disorder in the
Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM‐5; American Psychiatric
Association, May 2013) [2] (Table 1). It is also grouped under obsessive‐compulsive disorders
in the eleventh revision of the World Health Organization's International Classification of
Diseases and Related Health Problems (ICD‐11) [3].
• Recurrent pulling out of one’s hair, resulting in hair loss
• Repeated attempts to decrease or stop the pulling out of hair
• The hair pulling causes clinically significant distress or impairment in social, occupational, or other important areas
of functioning
• The hair pulling or hair loss is not attributable to another medical condition
• The hair pulling is not better explained by the symptoms of another mental disorder
Table 1. Diagnostic criteria (DSM‐5) [2].
1.2. Epidemiology
Trichotillomania occurs more frequently in females. The lifetime prevalence is 3.4% for women
and 1.5% for men [4]. The typical age of onset is between 5 and 12 years or early childhood to
adolescence, but it may occur in any age.
1.3. Pathogenesis
The onset of trichotillomania often occurs after a stressful event such as the divorce of parents,
loss of a loved one or unemployment [5]. Occasionally, trichotillomania is only seen while
sleeping, a condition known as sleep‐isolated trichotillomania [6].
1.4. Diagnosis
1.4.1. Clinical features
Patients may have other problems with self‐mutilation such as nail‐biting or dermatitis
artefacta. Approximately one‐third of the patients chew or swallow the hair they pull out,
which is called trichophagia and some of them develop trichobezoars, which is the accumu‐
lation of the patients’ own hair in the intestines. These trichobezoars may result in a “tail” that
lies along the duodenum, a phenomenon which is called Rapunzel Syndrome. Around 1% of
trichobezoar patients may need surgical intervention [4].
Symptom severity can be measured by using different validated instruments including
Massachusetts General Hospital Hair Pulling Scale that has seven parameters, rating symptom
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severity from 0 to 4 and assessing various aspects of plucking during the past seven days:
actual pulling, urge to pull, associated distress and perceived control, The Yale‐Brown
Obsessive‐Compulsive Scale, The Psychiatric Institute Trichotillomania Scale, The Trichotillo‐
mania Scale for Children, The Milwaukee Inventory for Styles of Trichotillomania‐Child
Version [7]. The MGHHS includes seven parameters, rating symptom severity from 0 to 4 and
assesses several aspects of hair pulling during the previous 7 days: urge to pull, actual pulling,
perceived control and associated distress. The MGHHS and its Dutch adaptation have been
reported to provide good psychometric properties [7].
Three subtypes of hair pulling have been described (Table 2).
• Early onset: occurring in young children, mostly under the age of 8; usually does not need any treatment.
• Automatic: occurring when the individual is busy with other activities, such as reading. This type affects 75% of
patients.
• Focused: occurs with the patient's attention and is associated with strong impulses to pull hair.
Table 2. Subtypes of trichotillomania.
Any part of the hair may be affected, but the targeted hair is mostly on the scalp (75%). The
eyelashes (53%), eyebrows (42%), pubic region (17%) and beard (10%) may also be involved,
but sometimes there is more than one location (17%) [8, 9]. The most affected scalp areas are
the frontoparietal region and vertex, while the least affected region is the occiput. The lower
eyelid is usually not involved; this is helpful to distinguish trichotillomania from alopecia
areata [10].
Alopecic plaques are usually located on the contralateral side of the dominant hand. There
may be more than one plaque. These plaques of hair loss most often have irregular shapes and
contain many broken hairs of varying lengths. The margins have normal and long hair.
The plucked hairs have fiber fractures and feel rough on examination. There are usually no
signs of inflammation in the plaques, but there may also be signs of excoriation, lichenification
and post‐inflammatory hyperpigmentation in some cases.
1.4.2. Dermoscopy
Trichoscopy may also be utilized for differential diagnosis. The trichotillomania plaque
includes broken and irregular coiled hair and hair density is decreased. Black dots, follicular
hemorrhages and V‐sign may be seen [11]. Trichoscopy is very useful in the differential
diagnosis of trichotillomania from alopecia areata where exclamation mark hairs, yellow dots
and proximal tapering hairs could be seen, in contrast with trichotillomania where trichopti‐
losis, pointed hairs, flame hairs, V‐sign, hook hairs, hair powder, follicular microhemorrhage
and tulip hairs are more characteristic. Follicular microhemorrhage meaning a red dot that
corresponds to a follicular ostium stuffed with blood clot, may support local trauma, a clue
for trichotillomania [12].




The diagnosis of trichotillomania is usually made by clinical examination and patient history.
However, occasionally especially in pediatric patient group both child and parents may deny
the possibility of pulling or plucking as a cause of hair loss and especially in localized involved
patients the diagnosis may be difficult. Histopathological examination may be necessary in
these patients. Follicules of normal size, increased catagen and telogen hairs (up to 75%) which
is a result of mechanical trauma to the hair frequently propelling anagen follicules into the
catagen phase, pigmentary defects and casts, evidence of traumatized hair bulbs and tricho‐
malacia (a complete but distorted, fully developed terminal hair in its bulb) are the most
common findings in histological examination of trichotillomania [13, 14]. Catagen hairs may
be present in areas that have recently been injured and telogen hairs may present after a few
weeks from pulling. Some hair follicles in anagen phase may be present, but they are usually
seen empty because of hair shaft avulsion. If the hair matrix and suprabulbar epithelium are
injured, but not severely disrupted, the follicle may remain in the anagen phase which may
produce a hair shaft. Follicles can show distortion of the bulbar epithelium and sometimes
conspicuous hemorrhage.
Hair shaft avulsion may deposit melanin pigment in the hair papilla and peribulbar connective
tissue [13, 14]. Frequently, chunks of pigmented hair matrix or cortex cells are torn from their
moorings during the plucking process and come to rest in superficial portions of the follicles.
These cells then shrink to form a dark black homogeneous clump called a pigment cast.
Pigment casts which are very characteristic for trichotillomania simply occur as the by‐product
of fragmented, ectopic matrix or cortical epithelium and usually seen in the isthmus or
infundibulum. Trichomalacia, which defines shaft abnormalities such as distorted in shape,
smaller than normal and incompletely cornified, is very characteristic for trichotillomania.
These injuries of pulling or plucking to the bulbar portions of follicles do not induce inflam‐
mation but may cause follicular microhemorrhage within the lower portion of the follicle. A
few eosinophils may be rarely seen around the lower portion of the traumatized follicule. Also
miniaturization of follicules is usually not seen in trichotillomania and absence of inflamma‐
tory infiltrate and loss of miniaturization are usually serve to differentiate it from alopecia
areata [14].
1.5. Differential diagnosis
Tinea capitis, alopecia areata, loose anagen hair, monilethrix, lichen planopilaris and secon‐
dary syphilis need to be considered in the differential diagnosis of trichotillomania. Tricho‐
scopy, medical history and scalp biopsy can be used to distinguish trichotillomania from other
diseases. Catagen and telogen hair numbers are found to be increased and usually there are
no signs of inflammation unless there is an infection in histologic examination. The number of
catagen hairs exceeds telogen hairs in chronic lesions. Perifollicular hemorrhage may be found
at the circumference of the hair bumbs [1].
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Potassium hydroxide examination, fungal culture and Wood's lamp examination may be
performed to exclude tinea capitis. The hair is weak and may easily be pulled out in tinea
capitis.
Alopecia areata plaques are oval and well‐demarked. A hair pull test may be helpful as a
diagnostic test for alopecia areata. Telogenic hairs may be pulled out easily in alopecia areata,
which indicates the activity of the disease in contrast with trichotillomania. Shaving the
involved area and waiting for the regrowth may also be useful for the diagnosis of trichotil‐
lomania. Alternatively, a small part of the hair is clipped near the scalp with scissors and the
hairs in trichotillomania display uniform hair regrowth.
Trichoscopy may also be utilized for differential diagnosis. Exclamation mark hairs and yellow
dots may be seen and white hairs are usually not involved in alopecia areata [11]. The tricho‐
tillomania plaque has broken and irregular coiled hair and the hair density is decreased. Black
dots, follicular hemorrhages, v‐sign may be seen [12].
1.6. Treatment
As mentioned above, trichotillomania is a psychiatric disorder with dermatological findings
which is characterized by compulsive avulsion of hair shafts leading to thin, ragged, broken
hairs on the affected region clinically [15]. The inability to control self‐pulling of hair resulting
in hair loss may progress into alopecia in long time.
Treatment procedure must be multidisciplinary including both dermatological but mainly
psychiatric approach to increase the effectiveness of the therapy and prevent relapse.
Cognitive and behavioral therapies (CBT), antipsychotic agents, selective serotonin reuptake
inhibitors (SSRI), tricyclic antidepressants are the main options of treatment [7, 16–18]. The
most appropiate therapeutic approach must be chosen according to the patient's age, medical
status and mental status.
Cognitive and behavioral therapies are the first steps of treatment and must be considered
together with pharmacotherapeutics in treatment [16, 19]. In a randomized controlled trial
with 7–8‐year‐olds, cognitive‐behavioral therapies alone were found to decrease the symptoms
in 75% of the participants [16].
The results about efficacy of SSRIs are conflicting. They were reported to be the safest and well‐
established medication choice. However, the clinical results show that medication, which is
usually an SSRI, in addition to CBT, is more successful, if CBT alone fails.
In a meta‐analysis which was reported in 2007, in which the efficacies of pharmacologic and
behavioral treatments were evaluated in treatment of trichotillomania, it was found that SSRIs
were not more effective than placebo. In two trials clomipramine was found to be more effective
compared with placebo. In three trials, it was shown that there is a beneficial effect of habit
reversal therapy compared with no intervention [20].
In another systematic review which was published in 2013, similar results were found. In two
included trials, fluoxetine was not more effective than placebo in reducing the mean severity
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rating of hair pulling. Clomipramine was found to be more effective than placebo, although 3
of 10 participants receiving clomipramine dropped out because of drug‐related adverse effects
[21].
At last, in a recent meta‐analysis of 11 randomized trials, the efficacy of behavioral therapy
and SSRI for the treatment of trichotillomania; the outcome measure was the standardized
mean difference of change in hair pulling [22]. This publication demonstrated a large effect for
behavioral therapy and only a moderate effect for SSRI. A greater treatment effect was reported
for clomipramine in two included trials [22].
The side effects and limited efficacy of pharmacological treatment, especially in pediatric
population and difficulty in long‐term maintenance of behavioral therapies require alternative
options of treatment. The glutamatergic system dysregulation is involved in obsessive‐
compulsive disorders etiology and it has been reported that N‐acetyl‐cysteine (NAC) might
have a therapeutic effect on these entities by acting on the glutamatergic system and reducing
oxidative stress [23]. It was reported as a safe and effective treatment option given 1200 mg/d
per os. The efficacy of the glutamate modulator NAC was evaluated in a small randomized
trial including 50 adults with trichotillomania [24]. N‐acetylcysteine was more effective than
placebo in reducing hair‐pulling symptoms as measured by the Massachusetts General
Hospital Hair Pulling Scale. A subsequent trial in children and adolescents did not find any
beneficial effect of NAC compared with placebo [24, 25].
2. Traction alopecia
2.1. Introduction
Traction alopecia (TA) is defined as loss of hair caused by repetitive or continuous and
prolonged tension applied to the hair [26–28]. It was first described using the terminology
alopecia groenlandica to refer to the hair loss attributed to tight ponytails which girls and women
wear in Greenland [29]. Although TA is more prevalent among females of African ancestry, it
has been described in a wide range of populations, including nurses, ballerinas, Sikh boys and
men, to name a few [30–34]. Research has convincingly demonstrated that certain habitual
practices of hairstyling are implicated in the pathogenesis of TA [35–39].
2.2. Epidemiology
Most of the population‐based studies concerning the prevalence of TA originate from South
Africa [35–37]. Overall, TA was found to be more common in females compared to males and
in women compared to girls, presumably due to a longer history of hairdressing [37]. Impor‐
tantly, in a large cohort of African adults in Cape Town, almost one‐third of women had
findings consistent with TA on scalp examination [35]. Of note, 17.1% of South African
schoolgirls had TA, with increasing prevalence rates from the first year of school to the last
year of high school [36]. A similar rate (18.4%) was observed in another study examining a
population of 201 African American girls from the United States [38]. In males, TA seems to
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be considerably less prevalent, however, two notable exceptions are Sikh boys and men, who
adhere to the religious practice of tightly knotting their scalp and/or beard hair and boys/men
wearing dreadlocks or cornrows [32–35, 40].
2.3. Pathogenesis
Traction alopecia is typically noncicatricial and reversible in its early stages, whereas it may
progressively result in permanent scarring in the long term [27, 28, 41]. It is well recognized
that traction causes an inflammatory, sometimes subclinical, folliculitis. The exact pathome‐
chanism leading from follicular inflammation to follicle damage and hair loss remains to be
elucidated; however, follicular miniaturization is considered to play a possible role [28, 42–44].
2.4. Predisposing factors
The factors predisposing to the development of TA fall into two major categories: (1) traumatic
hairstyling practices and (2) application of chemicals and/or heat to the hair [27]. It has been
shown that the combination of both factors greatly increases the risk of TA, cautioning against
the application of traction on chemically relaxed hair [36–38]. Importantly, hairdressing
practices causing symptoms such as stinging, pain, or crusting are associated with an increased
risk of TA [37, 39]. “Tenting” of the hair follicle, which manifests as elevation of the scalp skin
due to tight pulling, has been interpreted as a sign of excessive tension [27, 39, 43]. A more
recent literature review classified hairstyles into low risk, moderate risk and high‐risk [39].
Accordingly, the excessive use of very tight buns or ponytails belongs to the category of high‐
risk hairstyles, as do dreadlocks, cornrows and braids [38, 39, 45]. Another well‐recognized
factor associated with TA is the use of hair extensions, especially if applied to relaxed hair [39,
46]. According to the aforementioned review, other hairstyles such as braids and/or weaves
are considered high‐risk if they are combined with chemical relaxation of the hair [39].
Moreover, hairpins used to fix the nurse's cap to the scalp may be related to hair loss [30].
Alopecia initially presenting with a traumatic ulcer was described in association with hairstyles
requiring multiple hairpins [47].
2.5. Diagnosis
2.5.1. Clinical findings
Two main categories of TA have been recognized: marginal and nonmarginal [46]. The for‐
mer is more common and typically presents as bandlike loss of hair along the temporopar‐
ietal margin or frontal hairline (Figure 1) [48]. Marginal TA is usually attributable to
traumatic hairstyles, whereas nonmarginal TA may be caused by hairpins or buns [40, 47,
49]. A peculiar form of TA, termed “horseshoe pattern” by the authors, was described as a
result of weft hair extensions [46]. Hair loss in nonmarginal localizations may sometimes
present a diagnostic challenge and require more detailed history taking and/or histopatho‐
logical examination [27, 48].
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Figure 1. Marginal traction alopecia along the frontal hairline (A) and temporoparietal margin (B) in a woman who
applied excessive traction to her hair.
The earliest clinical sign of TA is considered to be perifollicular erythema in the areas of the
scalp exposed to maximum tension, which may progress to folliculocentric papules and
pustules. However, these initial findings may be unrecognized by the patient and physician
alike [22, 28, 31]. The presentation may be acute or more commonly, chronic and progressive.
Patients may provide a history of symptoms such as stinging or tenderness during hairdressing
practices [27]. As noted earlier, the alopecia is typically nonscarring in the early stages, but
may become irreversible later during the disease course, following a “biphasic” course [27].
Correspondingly, follicular markings tend to be decreased in the late stages of TA [27, 31, 43].
An important clinical caveat in the diagnosis of TA is the “fringe sign,” defined as the presence
of retained hairs along the frontal and/or temporal margin. This useful finding was observed
in early and late stages of TA alike (Figure 2) [43].
In general, TA is considered to have no systemic associations. Nonetheless, there is an
anecdotal report of a 25‐year‐old woman with prolonged traction resulting in a combination
of TA, cutis verticis gyrata and intractable headache. Her headache resolved as she was advised
to change her habitual hairstyle, which also stopped further hair loss [50].
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Figure 2. “Fringe sign” demonstrated in a woman with longstanding traction alopecia as a group of retained hairs
along the temporoparietal hairlines and located in front of the alopecic patches bilaterally.
2.5.2. Dermoscopy
Dermoscopy may be utilized as a useful aid to confirm the clinical diagnosis of TA and/or
differentiate it from other entities presenting with hair loss. In a cross‐sectional study from
Korea, broken hairs and black dots were observed in 100 and 92% of patients with TA,
respectively. Of these findings, broken hairs were noted in all patients with trichotillomania,
as well (Figure 3). Other dermoscopic findings associated with TA in this study were clustered
short vellus hairs, yellow dots and atypical red vessels, with decreasing frequency [51]. The
presence of hair casts has been emphasized as an important dermoscopic sign of TA, described
as cylindrical structures encircling the proximal hair shafts [52]. It has been demonstrated that
observation of hair casts on dermoscopic examination is an indicator of ongoing traction [53]
and should be interpreted as a warning sign that hairstyle changes should be implemented to
halt the progression of alopecia [52]. More recently, the trichoscopic finding of “flame
hairs”was reviewed in a population of patients with various hair disorders. Of note, flame
hairs were noted in slightly more than one half of the patients with trichotillomania, whereas
they were observed in less than 5% of patients with TA. This disparity was attributed by the
authors to the extent of the acute mechanical damage to the hair follicle being more prominent
in trichotillomania compared to that in TA [54].
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Figure 3. Broken and irregular coiled hairs, decreased hair density in dermoscopic examination.
Figure 4. (A) Perifollicular fibrosis on superficial dermis  and an anagen follicule with hair shaft avulsion ‐
H&Ex100, (B) catagen/telogen hair follicules‐ H&Ex40, (C) intrafollicular erythrocytes  and perifollicular fibrosis
 H&Ex400 and (D) an empty follicule with hair shaft avulsion  H&E ×200.
2.5.3. Histopathology
Histologic findings of TA parallel the biphasic course of the disease mentioned previously [27].
Early stages of TA are considered to resemble trichotillomania, whereas more advanced stages
of TA are similar to “burned‐out” forms of cicatricial alopecia [55]. More specifically, early TA
is characterized by increased numbers of telogen and catagen hairs and trichomalacia. In
contrast to primary scarring alopecias, sebaceous glands are generally preserved in TA
(Figure 4). With prolonged traction, terminal follicles tend to decrease in number and are
progressively replaced by fibrous tracts [27, 28, 43]. Furthermore, vellus‐sized hairs may be
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observed on histology which are thought to correspond to the aforementioned “fringe sign”
noted on physical examination [27]. Differentiation of late‐stage TA from primary scarring
alopecias may be challenging and it has been demonstrated that transverse sections may be
advantageous compared to vertical sections in differential diagnosis [56].
2.6. Differential diagnosis
The clinical differential diagnosis of TA depends on the distribution pattern of hair loss. For
marginal type TA, the most important entities to be considered in the differential diagnosis
are alopecia areata with an ophiasis pattern and frontal fibrosing alopecia [27, 43]. A notewor‐
thy caveat is that TA only affects scalp hair exposed to traction, whereas body hair, eyebrows
and/or nails may be involved in alopecia areata or frontal fibrosing alopecia [27]. Another
important differential diagnosis is androgenetic alopecia. These two conditions may also
coexist and in fact androgenetic alopecia is thought to predispose an individual to the
development of TA due to the miniaturized hairs [30, 40, 43]. Nonmarginal TA, on the other
hand, may be considered within the differential diagnosis of a broad range of conditions,
including alopecia areata, trichotillomania, telogen effluvium and discoid lupus erythemato‐
sus [40, 48].
Central centrifugal cicatricial alopecia (CCCA) is another condition mainly seen in females of
African descent [57]. The relationship between traction/TA and CCCA remains controversial
[58]. Ackerman and coauthors categorized CCCA as a form of TA, [59] and a retrospective
comparative study detected a strong association between CCCA and the use of tractional
hairstyles with artificial hair extensions [60]. However, a more recent study failed to reveal an
association between CCCA and tractional hairstyles. Interestingly, among more than 1000
female participants, not a single individual had a concomitant diagnosis of CCCA and TA in
the same study, suggesting that CCCA and TA may not be closely related [58].
2.7. Prevention and treatment
Prevention is an integral part of management of TA, as appropriate measures to eliminate
traction can stop hair loss before it becomes permanent [27, 28, 61]. It is important to recog‐
nize that TA most often originates during childhood and adolescence, suggesting that public
education should primarily focus on these at‐risk populations [27, 43, 44]. Prevention strat‐
egies have been detailed elsewhere [39, 44]. Briefly, management should rely on two main
principles: preferring loose hairstyles and avoiding heat and chemicals [27, 39]. Patients
may be encouraged to switch from high‐risk hairstyles to low‐risk hairstyles, such as loose
buns and ponytails [39]. An important message is that pain during hairstyling be interpret‐
ed as a sign that excessive tension has been applied and that particular hairstyle should bet‐
ter be avoided [39, 44].
Medical or surgical treatment should only be considered after traction has been minimized
[39]. There is a paucity of evidence‐based literature data with regard to the medical treat‐
ment of TA. Topical or intralesional corticosteroids and topical or systemic antibiotics may
be utilized to suppress the inflammation in the early stages of the disease [61].Topical min‐
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oxidil was described as effective in an anecdotal report [42] and recommended by some au‐
thors [27, 43, 61], although controlled trials are lacking. An interesting study demonstrated
the protective effect of piloerection induced by topical phenylephrine against the develop‐
ment of TA, suggesting a potential role of α1‐adrenergic receptor agonists in the treatment of
TA [41]. For extensive TA, surgical treatment has been described [45, 62]. Of note, a scoring
system was developed (“M‐TAS score”) to evaluate the severity of marginal type TA and
facilitate assessment of treatment effectiveness [63].
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